Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Maria McGlinch"'
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Table 1 Baseline characteristics of patients in Primary and Metastatic Tissue MDM Concordance Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6140eadd916a8d5b2bed2b2dd65a56
https://doi.org/10.1158/1078-0432.22478361.v1
https://doi.org/10.1158/1078-0432.22478361.v1
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Figure 1: The average level of all MDMs assayed from DNA extracted from primary and metastatic CRC tissues was not significantly different in Primary and Metastatic Tissue MDM Concordance Study. (A) Average level of all MDMs in metachron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa55c1af0d1fd3996e00f0184447d94
https://doi.org/10.1158/1078-0432.22478376
https://doi.org/10.1158/1078-0432.22478376
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Figure 2: The importance of individual MDMs and CEA in contribution to the performance of random forest model in classification of early CRC from healthy control in MDM Plasma CRC Early Primary Detection Study. MDM: methylated DNA marker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6856f3be73326d89e9ce7bb7a645975f
https://doi.org/10.1158/1078-0432.22478373.v1
https://doi.org/10.1158/1078-0432.22478373.v1
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Figure 4: Carcinoembryonic antigen (CEA) levels in nanograms per milliliter assayed from 10 microliters serum in the Early Detection experiment are 1.5 times higher than values assayed from 10 microliters of plasma in the Surveillance ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38bbefe7bb782ff94330fdbdbb6f7e8d
https://doi.org/10.1158/1078-0432.22478367
https://doi.org/10.1158/1078-0432.22478367
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Purpose:We aimed to assess the concordance of colorectal cancer–associated methylated DNA markers (MDM) in primary and metastatic colorectal cancer for feasibility in detection of distantly recurrent/metastatic colorectal cancer in plasma.Experimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::978104b8d9bca3fb69d652061094589f
https://doi.org/10.1158/1078-0432.c.6529932
https://doi.org/10.1158/1078-0432.c.6529932
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Table 2. Intraclass correlation coefficients (with 95% confidence intervals) between primary colorectal cancer and metastatic disease, either synchronous or metachronous indicate concordance of methylated DNA marker levels in total DNA e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b018f87744ea1cc3ed101c2cb7ec83f
https://doi.org/10.1158/1078-0432.22478358.v1
https://doi.org/10.1158/1078-0432.22478358.v1
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Figure 5: No difference in carcinoembryonic antigen (CEA) values in nanograms per milliliter (ng/mL) was seen in a comparison of available clinical serum versus experimental plasma samples from colorectal cancer patients with no evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d70d528f733d888974b3081b5b212bd
https://doi.org/10.1158/1078-0432.22478364
https://doi.org/10.1158/1078-0432.22478364
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Figure 3: The distribution of MDMs in MDM Plasma CRC Early Primary Detection Study (i.e., training data) and in MDM Plasma CRC Surveillance Study (i.e., Recurrence data). There are reference lines relative to the healthy controls (blue l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c96f0fdaaeb65e4cf76424b2cd3745
https://doi.org/10.1158/1078-0432.22478370.v1
https://doi.org/10.1158/1078-0432.22478370.v1
Autor:
John B. Kisiel, David A. Ahlquist, Graham P. Lidgard, Michael W. Kaiser, Hatim T. Allawi, Joleen M. Hubbard, Tsung-Teh Wu, Calise K. Berger, Maria McGlinch, Xiaoming Cao, Sara S. Then, William R. Taylor, Karen A. Doering, Kelli N. Burger, Patrick H. Foote, Douglas W. Mahoney, Hao Xie
Supplemental Table 3 Performance of MDMs in differentiating recurrent CRC from healthy controls in MDM Plasma CRC Surveillance Study. MDM: methylated DNA marker; CRC: colorectal cancer; AUC: area under the receiver operating characteristic curve; CI:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::561e0802396287ca93d265444e8d3a5b
https://doi.org/10.1158/1078-0432.22478355
https://doi.org/10.1158/1078-0432.22478355
Autor:
Kelli N. Burger, Douglas W. Mahoney, Graham P. Lidgard, Xiaoming Cao, Hao Xie, Tsung Teh Wu, Patrick H. Foote, Karen A. Doering, William R. Taylor, Hatim T. Allawi, Michael W. Kaiser, Joleen M. Hubbard, Calise K. Berger, David A. Ahlquist, Sara S. Then, John B. Kisiel, Maria McGlinch
Publikováno v:
Clin Cancer Res
Purpose: We aimed to assess the concordance of colorectal cancer–associated methylated DNA markers (MDM) in primary and metastatic colorectal cancer for feasibility in detection of distantly recurrent/metastatic colorectal cancer in plasma. Experim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d02d0748dbfba9d178d2aa05d3806506
https://doi.org/10.1158/1078-0432.ccr-20-2589
https://doi.org/10.1158/1078-0432.ccr-20-2589
